These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 292378)

  • 21. Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone.
    Douglas DL; Duckworth T; Kanis JA; Preston C; Beard DJ; Smith TW; Underwood I; Woodhead JS; Russell RG
    Arthritis Rheum; 1980 Oct; 23(10):1185-92. PubMed ID: 6448604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Short term treatment of Paget's disease with porcine calcitonin].
    Renier JC; Boasson M; Jallet P; Bernat M
    Rev Rhum Mal Osteoartic; 1973 Oct; 40(10):557-63. PubMed ID: 4797550
    [No Abstract]   [Full Text] [Related]  

  • 23. Calcitonin in the treatment of Paget's disease of bone.
    Johnston CC
    Ann Intern Med; 1972 Apr; 76(4):665-6. PubMed ID: 4268241
    [No Abstract]   [Full Text] [Related]  

  • 24. Remissions in Paget's disease produced by human synthetic calcitonin (calcitonin M).
    Woodhouse NJ; Reiner M; Kalu DN; Galante L; Joplin GF; MacIntyre I
    Clin Sci; 1970 Sep; 39(3):9P-10P. PubMed ID: 5459177
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].
    Ghiringhelli G; Fogel M; Varela de Rodríguez J; Casco C; Mautelén C; Nusimovich B
    Medicina (B Aires); 1982; 42(1):16-20. PubMed ID: 6813634
    [No Abstract]   [Full Text] [Related]  

  • 26. [Human calcitonin in the treatment of symptomatic Paget's disease].
    Mathä R; Kovarik J; Woloszczuk W; Plenk H; Willvonseder R; Böhler N; Seidl G; Höfer R
    Aktuelle Gerontol; 1983 Jan; 13(1):10-4. PubMed ID: 6131616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pamidronate sodium and calcitonin-resistant Paget's disease. Immediate response in a patient.
    Drake S; Massie JD; Postlethwaite AE; Palmieri GM
    Arch Intern Med; 1989 Feb; 149(2):401-3. PubMed ID: 2783843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skeletal blood flow in Paget's disease of bone and its response to calcitonin therapy.
    Wootton R; Reeve J; Spellacy E; Tellez-Yudilevich M
    Clin Sci Mol Med; 1978 Jan; 54(1):69-74. PubMed ID: 620495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control of osteitis deformans using glucagon, calcitonin, and mithramycin.
    Condon JR; Surtees J; Robinson V
    Postgrad Med J; 1981 Feb; 57(664):84-8. PubMed ID: 6455656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up observations on treatment in Paget's disease of bone.
    Kanis JA; Gray RE
    Clin Orthop Relat Res; 1987 Apr; (217):99-125. PubMed ID: 2951050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of Paget's disease with calcitonin.
    DeRose J; Avramides A; Baker RK; Wallach S
    Semin Drug Treat; 1972; 2(1):51-5. PubMed ID: 5065517
    [No Abstract]   [Full Text] [Related]  

  • 32. [Amino-hydroxy-propylidene biphosphonate in the treatment of Paget's disease resistant to calcitonin and/or etidronate].
    Miravet L; Kuntz D
    Rev Rhum Mal Osteoartic; 1989 Mar; 56(4):287-92. PubMed ID: 2496460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic salmon calcitonin. Treatment of Paget's disease and osteogenesis imperfecta.
    Goldfield EB; Braiker BM; Prendergast JJ; Kolb FO
    JAMA; 1972 Sep; 221(10):1127-9. PubMed ID: 4679000
    [No Abstract]   [Full Text] [Related]  

  • 34. APD in Paget's disease of bone. Role of the mononuclear phagocyte system?
    Bijvoet OL; Frijlink WB; Jie K; van der Linden H; Meijer CJ; Mulder H; van Paassen HC; Reitsma PH; te Velde J; de Vries E; van der Wey JP
    Arthritis Rheum; 1980 Oct; 23(10):1193-204. PubMed ID: 6448605
    [No Abstract]   [Full Text] [Related]  

  • 35. Human calcitonin in the treatment of Paget's bone disease.
    Woodhouse NJ; Bordier P; Fisher M; Joplin GF; Reiner M; Kalu DN; Foster GV; MacIntyre I
    Lancet; 1971 Jun; 1(7710):1139-43. PubMed ID: 4102856
    [No Abstract]   [Full Text] [Related]  

  • 36. Paget's disease of bone: assessment and management.
    Ibbertson HK; Fraser TR; Scott DJ; Cullen JC; Henley JW; Stephens ES; Tait B; Wattie DJ
    Drugs; 1979 Jul; 18(1):33-47. PubMed ID: 157870
    [No Abstract]   [Full Text] [Related]  

  • 37. Paget's bone disease: response to human calcitonin in patients resistant to salmon calcitonin.
    Rojanasathit S; Rosenberg E; Haddad JG
    Lancet; 1974 Dec; 2(7894):1412-5. PubMed ID: 4140329
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of Paget's bone disease with the bisphosphonate APD.
    Mautalen CA
    Henry Ford Hosp Med J; 1983; 31(4):244-8. PubMed ID: 6425243
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of Paget's disease of bone with salmon calcitonin (author's transl)].
    Kuhlencordt F; Ringe JD; Kruse HP
    Dtsch Med Wochenschr; 1981 Nov; 106(48):1620-3. PubMed ID: 7308002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac output in Paget's disease: response to long-term salmon calcitonin therapy.
    Woodhouse NJ; Crosbie WA; Mohamedally SM
    Br Med J; 1975 Dec; 4(5998):686. PubMed ID: 1203724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.